Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy

被引:1
|
作者
Yang, Hyun Kyung [1 ]
Park, Mi-Suk [1 ]
Han, Kyunghwa [2 ,3 ]
Eom, Geonsik [4 ]
Chung, Yong Eun [1 ]
Choi, Jin-Young [1 ]
Bang, Seungmin [5 ]
Kang, Chang Moo [6 ]
Seong, Jinsil [7 ]
Kim, Myeong-Jin [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Res Inst Radiol Sci, Dept Radiol, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Ctr Clin Imaging Data Sci, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Dept Med, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Severance Hosp, Inst Gastroenterol, Dept Internal Med,Coll Med, Seoul, South Korea
[6] Yonsei Univ, Severance Hosp, Pancreatobiliary Canc Ctr, Yonsei Canc Ctr,Dept Surg,Coll Med, Seoul, South Korea
[7] Yonsei Univ, Severance Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2024年 / 56卷 / 01期
关键词
Pancreatic ductal carcinoma; Prognosis; Neoadjuvant therapy; X-ray computed tomography; CA-19-9; antigen; CONSENSUS STATEMENT; CANCER; LEWIS; CHEMOTHERAPY; RESECTION; TUMOR; PHENOTYPE; CA19-9; SERUM;
D O I
10.4143/crt.2023.586
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Clinical prognostic criteria using preoperative factors were not developed for post-neoadjuvant therapy (NAT) surgery of pancreatic ductal adenocarcinoma (PDAC). We aimed to identify preoperative factors associated with overall survival (OS) in PDAC patients who underwent post-NAT curative-intent surgery and develop risk stratification criteria. Materials and Methods Consecutive PDAC patients who underwent post-NAT curative-intent surgeries between 2007 and 2020 were retrospectively analyzed. Demographic, laboratory, surgical, and histopathologic variables were collected. Baseline, preoperative, and interval changes of computed tomography (CT) findings proposed by the Society of Abdominal Radiology and the American Pancreatic Association were analyzed. Cox proportional hazard analysis was used to select preoperative variables associated with OS. We developed risk stratification criteria composed of the significant preoperative variables, i.e., post-NAT response criteria. We compared the discrimination performance of post-NAT response criteria with that of post-NAT pathological (yp) American Joint Cancer Committee TNM staging system. Results One hundred forty-five PDAC patients were included. Stable or increased tumor size on CT (hazard ratio [HR], 2.58; 95% confidence interval [CI], 1.58 to 4.21; p < 0.001) and elevated preoperative carbohydrate antigen 19-9 (CA19-9) level (HR, 1.98; 95% CI, 1.11 to 3.55; p=0.021) were independent factors of OS. The OS of the patient groups stratified by post-NAT response criteria which combined changes in tumor size and CA19-9 showed significant difference (p < 0.001). Such stratification was comparable to ypTNM staging in discrimination performance (difference of C-index, 0.068; 95% CI, -0.012 to 0.142). Conclusion "Any degree of decrease in tumor size on CT" and CA19-9 normalization or staying normal were independent favorable factors of OS. The combination of the two factors discriminated OS comparably to ypTNM staging.
引用
收藏
页码:247 / 258
页数:12
相关论文
共 50 条
  • [1] Risk stratification of pancreatic ductal adenocarcinoma patients undergoing curative-intent surgery after neoadjuvant therapy
    Yang, Hyun Kyung
    Park, Mi-Suk
    Han, Kyunghwa
    Eom, Geonsik
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Exploration of the lymphadenectomy strategy for elderly pancreatic ductal adenocarcinoma patients undergoing curative-intent resection
    Li, Zheng
    Zhang, Xiaojie
    Guo, Chunguang
    Sun, Chongyuan
    Li, Zefeng
    Fei, He
    Chen, Yingtai
    Zhao, Dongbing
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (05): : 1938 - 1951
  • [3] Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery
    Shannan M. Dickinson
    Caitlin A. McIntyre
    Juliana B. Schilsky
    Kate A. Harrington
    Scott R. Gerst
    Jessica R. Flynn
    Mithat Gonen
    Marinela Capanu
    Winston Wong
    Sharon Lawrence
    Peter J. Allen
    Eileen M. O’Reilly
    William R. Jarnagin
    Michael I. D’Angelica
    Vinod P. Balachandran
    Jeffrey A. Drebin
    T. Peter Kingham
    Amber L. Simpson
    Richard K. Do
    Abdominal Radiology, 2021, 46 : 1607 - 1617
  • [4] Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery
    Dickinson, Shannan M.
    McIntyre, Caitlin A.
    Schilsky, Juliana B.
    Harrington, Kate A.
    Gerst, Scott R.
    Flynn, Jessica R.
    Gonen, Mithat
    Capanu, Marinela
    Wong, Winston
    Lawrence, Sharon
    Allen, Peter J.
    O'Reilly, Eileen M.
    Jarnagin, William R.
    D'Angelica, Michael I.
    Balachandran, Vinod P.
    Drebin, Jeffrey A.
    Kingham, T. Peter
    Simpson, Amber L.
    Do, Richard K.
    ABDOMINAL RADIOLOGY, 2021, 46 (04) : 1607 - 1617
  • [5] Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma
    Slodkowski, Maciej
    Wronski, Marek
    Karkocha, Dominika
    Kraj, Leszek
    Smigielska, Kaja
    Jachnis, Aneta
    CANCERS, 2023, 15 (09)
  • [6] Neoadjuvant chemotherapy and disease recurrence after curative-intent surgery in patients with pancreatic adenocarcinoma: A single-center retrospective review.
    Alhamad, Khaled
    Alrifai, Nada
    Attah, Abraham Attah
    Shankar, Karthik
    Alnimer, Lynna
    Samhouri, Yazan
    Jayakrishnan, Thejus Thayyil
    Srinivasamaharaj, Srividya
    Monga, Dulabh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Improved Distant Metastasis-Free Survival with Aspirin Use in Patients Undergoing Curative-Intent Resection of Pancreatic Ductal Adenocarcinoma
    Sadek, Kareem
    Alsabbagh, Yaman
    Tice, Mary P.
    Poruk, Katherine E.
    Stauffer, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S282 - S282
  • [8] Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy
    Murata, Yasuhiro
    Ogura, Toru
    Hayasaki, Aoi
    Gyoten, Kazuyuki
    Ito, Takahiro
    Iizawa, Yusuke
    Fujii, Takehiro
    Tanemura, Akihiro
    Kuriyama, Naohisa
    Kishiwada, Masashi
    Sakurai, Hiroyuki
    Mizuno, Shugo
    PLOS ONE, 2022, 17 (04):
  • [9] Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery
    Mantas, Anna
    Liu, Dong
    Otto, Carlos Constantin
    Heij, Lara Rosaline
    Heise, Daniel
    Bruners, Philipp
    Lang, Sven Arke
    Ulmer, Tom Florian
    Neumann, Ulf Peter
    Bednarsch, Jan
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [10] Time to surgery is not an oncological risk factor in patients with cholangiocarcinoma undergoing curative-intent liver surgery
    Anna Mantas
    Dong Liu
    Carlos Constantin Otto
    Lara Rosaline Heij
    Daniel Heise
    Philipp Bruners
    Sven Arke Lang
    Tom Florian Ulmer
    Ulf Peter Neumann
    Jan Bednarsch
    Scientific Reports, 14